These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 8702227)

  • 1. Antitumor activity of menogaril alone, and in combination against human mammary cancer models in mice and rats.
    Yoshida M; Fujioka A; Nakano K; Kobunai T; Saito H; Toko T; Takeda S; Unemi N
    Anticancer Res; 1996; 16(3A):1155-9. PubMed ID: 8702227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity of menogaril against various malignant lymphoma cell lines and a human lymphoma xenograft in mice.
    Yoshida M; Fujioka A; Nakano K; Yuasa C; Toko T; Takeda S; Unemi N
    Anticancer Res; 1996; 16(5A):2875-9. PubMed ID: 8917401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with a new folate analog: activity of 10-ethyl-10-deaza-aminopterin compared to methotrexate with 5-fluorouracil and alkylating agents against advanced metastatic disease in murine tumor models.
    Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
    Cancer Treat Rep; 1987; 71(7-8):727-32. PubMed ID: 3607784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of the optimum clinical dosing schedule for menogaril from results with tumor-bearing mice.
    Yoshida M; Kobunai T; Nakano K; Saito H; Toko T; Takeda S; Unemi N
    Anticancer Res; 1996; 16(5A):2869-73. PubMed ID: 8917400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
    Ohe Y; Nakagawa K; Fujiwara Y; Sasaki Y; Minato K; Bungo M; Niimi S; Horichi N; Fukuda M; Saijo N
    Cancer Res; 1989 Aug; 49(15):4098-102. PubMed ID: 2472873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
    Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH
    Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proteasome inhibitor PS-341 in cancer therapy.
    Teicher BA; Ara G; Herbst R; Palombella VJ; Adams J
    Clin Cancer Res; 1999 Sep; 5(9):2638-45. PubMed ID: 10499643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer activities of orally administered menogaril against human stomach and breast cancers implanted in nude mice.
    Inaba M; Sato S; Yamori T; Tashiro T; Ohnishi Y; Maruo K; Ueyama Y; Tsuruo T
    Anticancer Res; 1992; 12(6B):1953-6. PubMed ID: 1295442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor efficacy of combination chemotherapy with UFT and cyclophosphamide against human breast cancer xenografts in nude mice.
    Haga S; Shimizu T; Imamura H; Watanabe O; Kinoshita J; Fukushima M; Kajiwara T
    Anticancer Res; 1999; 19(3A):1791-6. PubMed ID: 10470117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergism between the anticancer actions of 2-methoxyestradiol and microtubule-disrupting agents in human breast cancer.
    Han GZ; Liu ZJ; Shimoi K; Zhu BT
    Cancer Res; 2005 Jan; 65(2):387-93. PubMed ID: 15695378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MX2, a morpholino anthracycline, as a new antitumor agent against drug-sensitive and multidrug-resistant human and murine tumor cells.
    Watanabe M; Komeshima N; Nakajima S; Tsuruo T
    Cancer Res; 1988 Dec; 48(23):6653-7. PubMed ID: 3180075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantable mouse mammary adenocarcinoma 16/c as a model in experimental cancer therapy. III. Sensitivity to antitumor drugs.
    Rak J; Kuśnierczyk H; Strzadała L; Kłosiewicz S; Radzikowski C
    Arch Immunol Ther Exp (Warsz); 1989; 37(3-4):389-97. PubMed ID: 2639635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
    Cao S; McGuire JJ; Rustum YM
    Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antitumor effect of lowered doses of cytostatics combined with new analogs of vitamin D in mice.
    Wietrzyk J; Nevozhay D; Filip B; Milczarek M; Kutner A
    Anticancer Res; 2007; 27(5A):3387-98. PubMed ID: 17970085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antitumor activities of orally administered 7-con-0-methylnogarol (TUT-7)].
    Sugimoto Y; Matsuo K; Takeda S; Yamada Y; Tsukagoshi S
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):353-8. PubMed ID: 2138003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedule-dependent synergism of vinorelbine and 5-fluorouracil/UFT against non-small cell lung cancer.
    Matsumoto S; Igishi T; Hashimoto K; Kodani M; Shigeoka Y; Nakanishi H; Touge H; Kurai J; Makino H; Takeda K; Yasuda K; Hitsuda Y; Shimizu E
    Int J Oncol; 2004 Nov; 25(5):1311-8. PubMed ID: 15492820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination therapy of a new platinum complex, DWA2114R with various antitumor agents against mouse tumors in vivo].
    Akamatsu K; Endo K; Tsunenari T; Matsumoto T; Kaiho S; Morikawa K; Koizumi M; Mitsui H; Koizumi K
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):229-35. PubMed ID: 1736835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of (2''R)-4'-O-tetrahydropyranyl adriamycin on human gastric cancer cell lines in vitro and in vivo.
    Saikawa Y; Kubota T; Kuo TH; Furukawa T; Kase S; Tanino H; Ishibiki K; Kitajima M; Hoffman RM
    Anticancer Res; 1994; 14(2A):469-73. PubMed ID: 8017850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. cis-Amminedichloro(2-methylpyridine) platinum(II) (AMD473), a novel sterically hindered platinum complex: in vivo activity, toxicology, and pharmacokinetics in mice.
    Raynaud FI; Boxall FE; Goddard PM; Valenti M; Jones M; Murrer BA; Abrams M; Kelland LR
    Clin Cancer Res; 1997 Nov; 3(11):2063-74. PubMed ID: 9815598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.